• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Accurate relapse prediction in ANCA-associated vasculitis-the search for the Holy Grail.

作者信息

Specks Ulrich

机构信息

Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota

出版信息

J Am Soc Nephrol. 2015 Mar;26(3):505-7. doi: 10.1681/ASN.2014080817. Epub 2014 Oct 16.

DOI:10.1681/ASN.2014080817
PMID:25324503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4341490/
Abstract
摘要

相似文献

1
Accurate relapse prediction in ANCA-associated vasculitis-the search for the Holy Grail.抗中性粒细胞胞浆抗体相关性血管炎中准确的复发预测——寻找圣杯
J Am Soc Nephrol. 2015 Mar;26(3):505-7. doi: 10.1681/ASN.2014080817. Epub 2014 Oct 16.
2
Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.在诱导缓解后仍为胞质型抗中性粒细胞胞质抗体阳性的新诊断的蛋白酶3抗中性粒细胞胞质抗体相关血管炎患者中，延长与标准硫唑嘌呤维持治疗的比较：一项随机临床试验
Nephrol Dial Transplant. 2016 Sep;31(9):1453-9. doi: 10.1093/ndt/gfw211. Epub 2016 May 30.
3
Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report.抗中性粒细胞胞外诱捕体抗体在抗中性粒细胞胞浆抗体相关性血管炎复发患者中的应用：一例报告。
BMC Nephrol. 2018 Jun 22;19(1):145. doi: 10.1186/s12882-018-0953-y.
4
With complements from ANCA mice.来自抗中性粒细胞胞浆抗体小鼠的补体。
J Am Soc Nephrol. 2014 Feb;25(2):207-9. doi: 10.1681/ASN.2013101043. Epub 2013 Oct 31.
5
Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.日本抗中性粒细胞胞浆抗体相关性血管炎患者中，复发率和临床表型在自身抗体亚型方面的差异。
Mod Rheumatol. 2017 Jan;27(1):95-101. doi: 10.1080/14397595.2016.1192760. Epub 2016 Jun 20.
6
The role of trimethoprim/sulfametoxazole in reducing relapses and risk of infections in ANCA-associated vasculitis: a meta-analysis.复方磺胺甲噁唑在降低抗中性粒细胞胞浆抗体相关性血管炎复发和感染风险中的作用：一项荟萃分析。
Rheumatology (Oxford). 2021 Aug 2;60(8):3553-3564. doi: 10.1093/rheumatology/keab267.
7
Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission.抗中性粒细胞胞质抗体相关性垂体血管炎肾缓解后无抗中性粒细胞胞质抗体升高的异位复发。
Intern Med. 2020 Dec 15;59(24):3187-3193. doi: 10.2169/internalmedicine.4731-20. Epub 2020 Aug 12.
8
Cholesterol Emboli Co-Existing with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in a 76-Year-Old Woman.76 岁女性中并存的胆固醇栓塞与抗中性粒细胞胞浆抗体相关性血管炎。
Tohoku J Exp Med. 2020 May;251(1):61-68. doi: 10.1620/tjem.251.61.
9
Recurrence of ANCA-associated vasculitis in a patient with kidney trasplant.肾移植患者中抗中性粒细胞胞浆抗体相关性血管炎的复发
Nefrologia. 2016;36(2):176-80. doi: 10.1016/j.nefro.2015.08.011. Epub 2016 Feb 2.
10
[Pathophysiology and Laboratory Findings in Patients with ANCA-Associated Vasculitis].[抗中性粒细胞胞浆抗体相关血管炎患者的病理生理学及实验室检查结果]
Rinsho Byori. 2015 Oct;63(10):1213-9.

引用本文的文献

1
Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study.在诱导缓解时将低剂量环磷酰胺添加到利妥昔单抗中可能会延长抗中性粒细胞胞浆抗体血管炎患者的无复发生存期：一项回顾性研究。
J Transl Autoimmun. 2022 Dec 15;6:100178. doi: 10.1016/j.jtauto.2022.100178. eCollection 2023.
2
Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients.高敏流式细胞术检测抗中性粒细胞胞质抗体相关性血管炎患者利妥昔单抗治疗后残留 B 细胞。
Front Immunol. 2020 Dec 15;11:566732. doi: 10.3389/fimmu.2020.566732. eCollection 2020.
3
Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis.在抗中性粒细胞胞浆抗体相关性血管炎中，针对蛋白酶3的抗中性粒细胞胞浆抗体系列检测的临床应用
Front Immunol. 2020 Sep 3;11:2053. doi: 10.3389/fimmu.2020.02053. eCollection 2020.
4
PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab.PR3-ANCAs 预测利妥昔单抗治疗后抗中性粒细胞胞浆抗体相关性血管炎患者的复发。
Nephrol Dial Transplant. 2021 Jul 23;36(8):1408-1417. doi: 10.1093/ndt/gfaa066.
5
Imbalance of Circulatory T Follicular Helper and T Follicular Regulatory Cells in Patients with ANCA-Associated Vasculitis.循环性滤泡辅助性 T 细胞与滤泡调节性 T 细胞失衡与抗中性粒细胞胞浆抗体相关性血管炎。
Mediators Inflamm. 2019 Dec 2;2019:8421479. doi: 10.1155/2019/8421479. eCollection 2019.
6
Impact of caring for someone with a rare rheumatic condition, views from patients and informal carers-the need for cat-like vigilance.照顾患有罕见风湿性疾病患者的影响：患者及非正式照料者的观点——需保持猫一样的警觉
Rheumatol Adv Pract. 2019 Feb 1;3(1):rkz003. doi: 10.1093/rap/rkz003. eCollection 2019.
7
Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know.抗中性粒细胞胞浆抗体相关血管炎的中枢神经系统受累：神经科医生需要了解的内容。
Front Neurol. 2019 Jan 10;9:1166. doi: 10.3389/fneur.2018.01166. eCollection 2018.
8
ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.抗中性粒细胞胞质抗体相关性血管炎 - 使用抗中性粒细胞胞质抗体特异性对患者进行分类的临床应用。
Nat Rev Rheumatol. 2016 Oct;12(10):570-9. doi: 10.1038/nrrheum.2016.123. Epub 2016 Jul 28.
9
Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3.影响抗中性粒细胞胞浆抗体（针对蛋白酶 3）连续检测临床效用的因素。
Arthritis Rheumatol. 2016 Jul;68(7):1700-10. doi: 10.1002/art.39637.

本文引用的文献

1
ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease.抗中性粒细胞胞浆抗体作为复发的预测指标：对有肾脏受累的患者有用，但对无肾脏疾病的患者无用。
J Am Soc Nephrol. 2015 Mar;26(3):537-42. doi: 10.1681/ASN.2013111233. Epub 2014 Oct 16.
2
Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.利妥昔单抗治疗抗中性粒细胞胞浆抗体相关性血管炎的复发。
Arthritis Rheumatol. 2014 Nov;66(11):3151-9. doi: 10.1002/art.38788.
3
Brief report: The value of a patient global assessment of disease activity in granulomatosis with polyangiitis (Wegener's).简要报告：在肉芽肿伴多血管炎（韦格纳氏）中，患者疾病活动的整体评估的价值。
Arthritis Rheumatol. 2014 Feb;66(2):428-32. doi: 10.1002/art.38248.
4
Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.anca 相关性血管炎的损害：来自欧洲血管炎研究组（euvas）治疗试验的长期数据。
Ann Rheum Dis. 2015 Jan;74(1):177-84. doi: 10.1136/annrheumdis-2013-203927. Epub 2013 Nov 15.
5
Efficacy of remission-induction regimens for ANCA-associated vasculitis.缓解诱导方案治疗抗中性粒细胞胞质抗体相关性血管炎的疗效。
N Engl J Med. 2013 Aug 1;369(5):417-27. doi: 10.1056/NEJMoa1213277.
6
Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.抗中性粒细胞胞质抗体相关性血管炎的发病机制：干预的新可能。
Am J Kidney Dis. 2013 Dec;62(6):1176-87. doi: 10.1053/j.ajkd.2013.05.009. Epub 2013 Jun 28.
7
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.2012年修订的国际 Chapel Hill 共识会议血管炎命名法
Arthritis Rheum. 2013 Jan;65(1):1-11. doi: 10.1002/art.37715.
8
Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.抗中性粒细胞胞浆自身抗体血管炎的分类：抗中性粒细胞胞浆自身抗体对髓过氧化物酶或蛋白酶3的特异性在疾病识别和预后中的作用
Arthritis Rheum. 2012 Oct;64(10):3452-62. doi: 10.1002/art.34562.
9
Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis.重新探讨抗中性粒细胞胞浆抗体相关性血管炎的临床表型分类：聚类分析。
Ann Rheum Dis. 2013 Jun;72(6):1003-10. doi: 10.1136/annrheumdis-2012-201750. Epub 2012 Sep 8.
10
Treatment of ANCA-associated vasculitides (AAV).抗中性粒细胞胞质抗体相关性血管炎（AAV）的治疗。
Autoimmun Rev. 2013 Feb;12(4):483-6. doi: 10.1016/j.autrev.2012.08.007. Epub 2012 Aug 16.